Peter McLaughlin

26.0k total citations · 4 hit papers
404 papers, 18.0k citations indexed

About

Peter McLaughlin is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Peter McLaughlin has authored 404 papers receiving a total of 18.0k indexed citations (citations by other indexed papers that have themselves been cited), including 266 papers in Pathology and Forensic Medicine, 150 papers in Oncology and 117 papers in Genetics. Recurrent topics in Peter McLaughlin's work include Lymphoma Diagnosis and Treatment (258 papers), Chronic Lymphocytic Leukemia Research (113 papers) and Viral-associated cancers and disorders (89 papers). Peter McLaughlin is often cited by papers focused on Lymphoma Diagnosis and Treatment (258 papers), Chronic Lymphocytic Leukemia Research (113 papers) and Viral-associated cancers and disorders (89 papers). Peter McLaughlin collaborates with scholars based in United States, Germany and Canada. Peter McLaughlin's co-authors include Fernando Cabanillas, Fredrick B. Hagemeister, Jorge Romaguera, Maria Alma Rodriguez, Anas Younes, F Swan, Barbara Pro, A.J. Grillo-López, Luis Fayad and Christine A. White and has published in prestigious journals such as Science, JAMA and Journal of Clinical Investigation.

In The Last Decade

Peter McLaughlin

400 papers receiving 17.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1998 2.2k citations Peter McLaughlin, A.J. Grillo-López et al. Journal of Clinical Oncology profile →
Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment

2000 523 citations Peter McLaughlin, David G. Maloney et al. Journal of Clinical Oncology profile →
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

2009 506 citations Massimo Federico, Monica Bellei et al. Journal of Clinical Oncology profile →
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

1988 487 citations Fernando Cabanillas, Peter McLaughlin et al. Blood profile →

Peers

Countries citing papers authored by Peter McLaughlin

Since Specialization

Citations

This map shows the geographic impact of Peter McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter McLaughlin more than expected).

Fields of papers citing papers by Peter McLaughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter McLaughlin. The network helps show where Peter McLaughlin may publish in the future.

Co-authorship network of co-authors of Peter McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Peter McLaughlin. A scholar is included among the top collaborators of Peter McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter McLaughlin. Peter McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuroscience explanations really do satisfy: A systematic review and meta-analysis of the seductive allure of neuroscience 2023 ·Public Understanding of Science ·Elizabeth Bennett, Peter McLaughlin	8
2	The Coming Hypersonic Era 2023 ·SHILAP Revista de lepidopterología ·Peter McLaughlin	1
3	Biphasic effects of 5-HT1A agonism on impulsive responding are dissociable from effects on anxiety in the variable consecutive number task 2019 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·(unknown), (unknown), (unknown), (unknown), Peter McLaughlin	7
4	Long term results of a phase 2 study of vincristine sulfate liposome injection ( M arqibo ^® ) substituted for non‐liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non‐ H odgkin lymphomas 2013 ·British Journal of Haematology ·Fredrick B. Hagemeister, Maria Alma Rodriguez, Steven R. Deitcher, Anas Younes, Luis Fayad, André Goy, Nam H. Dang, Arthur Forman, Peter McLaughlin, Leonard Jeffrey Medeiros, Barbara Pro, Jorge Romaguera, Felipe Samaniego, Jeffrey A. Silverman, Andreas H. Sarris, Fernando Cabanillas	24
5	Effects of a novel CB1 agonist on visual attention in male rats: Role of strategy and expectancy in task accuracy. 2013 ·Experimental and Clinical Psychopharmacology ·(unknown), Ganesh A. Thakur, (unknown), (unknown), (unknown), Alexandros Makriyannis, Peter McLaughlin	8
6	Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database 2012 ·Journal of Clinical Oncology ·Philippe Solal‐Céligny, Monica Bellei, Luigi Marcheselli, Emanuela Anna Pesce, Stefano Pileri, Peter McLaughlin, Stefano Luminari, Barbara Pro, Silvia Montoto, Andrés J.M. Ferreri, Éric Deconinck, Nöel Milpied, Leo I. Gordon, Massimo Federico	88
7	Treatment recommendations for radioimmunotherapy in follicular lymphoma: a consensus conference report 2011 ·Leukemia & lymphoma ·Thomas E. Witzig, Paul A. S. Fishkin, Leo I. Gordon, Stephanie A. Gregory, Samuel A. Jacobs, Roger M. Macklis, Peter McLaughlin, Oliver W. Press, Andrew D. Zelenetz	25
8	Phase II Study of Yttrium-90–Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell Lymphoma 2009 ·Journal of Clinical Oncology ·Michael Wang, Yasuhiro Oki, Barbara Pro, Jorge Romaguera, Maria Alma Rodriguez, Felipe Samaniego, Peter McLaughlin, Frederick Hagemeister, Sattva S. Neelapu, Amanda Copeland, Barry I. Samuels, Evelyne M. Loyer, Yuan Ji, Anas Younes	66
9	The social and economic roots of the scientific revolution : texts by Boris Hessen and Henryk Grossmann 2009 ·Max Planck Institute for Plasma Physics ·Gideon Freudenthal, Peter McLaughlin	6
10	Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab 2008 ·Blood ·Issa F. Khouri, Peter McLaughlin, Rima M. Saliba, Chitra Hosing, Martin Körbling, Ming S. Lee, L. Jeffrey Medeiros, Luis Fayad, Felipe Samaniego, Amin Alousi, Paolo Anderlini, Daniel R. Couriel, Marcos de Lima, Sergio Giralt, Sattva S. Neelapu, Naoto T. Ueno, Barry I. Samuels, Fredrick Hagemeister, Larry W. Kwak, Richard E. Champlin	215
11	The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats 2005 ·Behavioural Pharmacology ·Peter McLaughlin, Carrie M. Brown, (unknown), Ganesh A. Thakur, Dai Lu, A. Makriyannis, John D. Salamone	12
12	Recovery of natural killer cell counts after one course of CHOP chemotherapy is diminished in patients older than 60 compared to patients younger than 60. 2004 ·Cancer Research ·(unknown), Maria Alma Rodriguez, Fernando Cabanillas, Nam H. Dang, Peter McLaughlin, Fredrick B. Hagemeister, Barbara Pro, Jorge Romaguera, Anas Younes, Elizabeth A. Grimm	2
13	Randomized comparison of frontline alternating chemotherapy versus brief induction followed by autologous stem cell transplant for aggressive lymphomas 2003 ·Blood ·Maria Alma Rodriguez, Koen van Besien, Fredrick B. Hagemeister, Sergio Giralt, Peter McLaughlin, James Gajewski, Jorge Romaguera, Issa F. Khouri, Anas Younes, Fernando Cabanillas, Richard E. Champlin	2
14	Liposomal vincristine in relapsed non-Hodgkin's lymphomas: Early results of an ongoing phase II trial 2000 ·Annals of Oncology ·A H Sarris, Frederick Hagemeister, Jorge Romaguera, Maritza Rodríguez, Peter McLaughlin, Apostolia M. Tsimberidou, L. Jeffrey Medeiros, Barry I. Samuels, O. Pate, (unknown), Hagop M. Kantarjian, (unknown), Fernando Cabanillas	109
15	Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival 1999 ·Annals of Oncology ·A H Sarris, K. O. Kliche, (unknown), A. Preti, Søren M. Bentzen, Clotilde M. Jackow, Osvaldo Daniel Messina, William Pugh, Fredrick B. Hagemeister, Peter McLaughlin, Maria Alma Rodriguez, Jorge Romaguera, Herbert A. Fritsche, Thomas E. Witzig, Madeleine Duvic, M Andreeff, Fernando Cabanillas	132
16	Immanuel Kant, Kritik der reinen Vernunft, edited by Jens Timmermann, Felix Meiner Verlag Immanuel Kant, Critique of Pure Reason, translated by Werner S. Pluhar with an Introduction by Patricia W. Kitcher, Immanuel Kant, Critique of Pure Reason, tran 1999 ·Erkenntnis ·Peter McLaughlin	14
17	Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma 1998 ·Annals of Oncology ·Neil L. Berinstein, A.J. Grillo-López, Christine A. White, Isabelle Bence‐Bruckler, David G. Maloney, M. S. Czuczman, (unknown), J. Rosenberg, Peter McLaughlin, Diying Shen	444
18	Kants Kritik der teleologischen Urteilskraft 1989 ·Journal of the History of Biology ·Peter McLaughlin	14
19	The Thin White Line: Rhodesia's Armed Forces Since the Second World War 1978 ·Zambezia The Journal of Humanities of the University of Zimbabwe ·Peter McLaughlin	1
20	Effect of bran and cholestyramine on plasma lipids in monkeys 1976 ·American Journal of Clinical Nutrition ·(unknown), Peter McLaughlin, (unknown), (unknown), (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact